22 Jan Umoja Biopharma
Posted at 21:24h
in
David Fontana, Ph.D., Chief Operating and Business Officer
April 10 | 3:45pm | Salone dei Cavalieri, Section 2
Seattle, WA
(Private)
Umioja Biopharma is the leader in in vivo CAR T delivery with its novel platform named VivoVec. As a private company we employ ~170 employees between our Seattle HC and our state of art GMP manufacturing facility in CO. We have recently shared best in field non-human promate data and two of our in vivo products will be in the clinic in 2024. Umoja also has an iPSC platform.
